TY - JOUR
T1 - Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region
AU - Ponirakis, Georgios
AU - Elhadd, Tarik
AU - Al Ozairi, Ebaa
AU - Brema, Imad
AU - Chinnaiyan, Subitha
AU - Taghadom, Etab
AU - Al Kandari, Jumana
AU - Al Wotayan, Rehab
AU - Al Ozairi, Abdulla
AU - Aljohani, Naji
AU - AlMistehi, Wael
AU - Al Qahtani, Nora
AU - Khan, Shawana
AU - Dabbous, Zeinab
AU - Siddique, Mashhood A.
AU - Petropoulos, Ioannis N.
AU - Khan, Adnan
AU - Almuhannadi, Hamad
AU - Ashawesh, Khaled A.E.
AU - Dukhan, Khaled M.
AU - Mahfoud, Ziyad R.
AU - Zirie, Mahmoud A.
AU - Jayyousi, Amin
AU - Malik, Rayaz A.
N1 - Publisher Copyright:
© 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
PY - 2022/9
Y1 - 2022/9
N2 - Aims/Introduction: This study determined the prevalence and risk factors for diabetic peripheral neuropathy (DPN), painful DPN and diabetic foot ulceration (DFU) in patients with type 2 diabetes in secondary healthcare in Qatar, Kuwait and the Kingdom of Saudi Arabia. Materials and Methods: Adults aged 18–85 years with type 2 diabetes were randomly enrolled from secondary healthcare, and underwent clinical and metabolic assessment. DPN was evaluated using vibration perception threshold and neuropathic symptoms and painful Diabetic Peripheral Neuropathy was evaluated using the Douleur Neuropathique 4 questionnaire. Results: A total of 3,021 individuals were recruited between June 2017 and May 2019. The prevalence of DPN was 33.3%, of whom 52.2% were at risk of DFU and 53.6% were undiagnosed. The prevalence of painful DPN was 43.3%, of whom 54.3% were undiagnosed. DFU was present in 2.9%. The adjusted odds ratios for DPN and painful DPN were higher with increasing diabetes duration, obesity, poor glycemic control and hyperlipidemia, and lower with greater physical activity. The adjusted odds ratio for DFU was higher with the presence of DPN, severe loss of vibration perception, hypertension and vitamin D deficiency. Conclusions: This is the largest study to date from the Middle East showing a high prevalence of undiagnosed DPN, painful DPN and those at risk of DFU in patients with type 2 diabetes, and identifies their respective risk factors.
AB - Aims/Introduction: This study determined the prevalence and risk factors for diabetic peripheral neuropathy (DPN), painful DPN and diabetic foot ulceration (DFU) in patients with type 2 diabetes in secondary healthcare in Qatar, Kuwait and the Kingdom of Saudi Arabia. Materials and Methods: Adults aged 18–85 years with type 2 diabetes were randomly enrolled from secondary healthcare, and underwent clinical and metabolic assessment. DPN was evaluated using vibration perception threshold and neuropathic symptoms and painful Diabetic Peripheral Neuropathy was evaluated using the Douleur Neuropathique 4 questionnaire. Results: A total of 3,021 individuals were recruited between June 2017 and May 2019. The prevalence of DPN was 33.3%, of whom 52.2% were at risk of DFU and 53.6% were undiagnosed. The prevalence of painful DPN was 43.3%, of whom 54.3% were undiagnosed. DFU was present in 2.9%. The adjusted odds ratios for DPN and painful DPN were higher with increasing diabetes duration, obesity, poor glycemic control and hyperlipidemia, and lower with greater physical activity. The adjusted odds ratio for DFU was higher with the presence of DPN, severe loss of vibration perception, hypertension and vitamin D deficiency. Conclusions: This is the largest study to date from the Middle East showing a high prevalence of undiagnosed DPN, painful DPN and those at risk of DFU in patients with type 2 diabetes, and identifies their respective risk factors.
KW - Diabetic foot ulceration
KW - Diabetic peripheral neuropathy
KW - Painful diabetic peripheral neuropathy
UR - http://www.scopus.com/inward/record.url?scp=85129265642&partnerID=8YFLogxK
U2 - 10.1111/jdi.13815
DO - 10.1111/jdi.13815
M3 - Article
C2 - 35445568
AN - SCOPUS:85129265642
SN - 2040-1116
VL - 13
SP - 1551
EP - 1559
JO - Journal of Diabetes Investigation
JF - Journal of Diabetes Investigation
IS - 9
ER -